BLACKLEDGE, JR., CHARLES WILLIAM,BURGESS, JOELLE LORRAINE,JOHNSON, NEIL W.,KASPAREC, JIRI,KNIGHT, STEVEN DAVID,LAFRANCE III, LOUIS V.,LUENGO, JUAN I.,MILLER, WILLIAM HENRY,NEWLANDER, KENNETH ALLEN,ROM,BLACKLEDGE, JR., Charles William,BURGESS, Joelle Lorraine,JOHNSON, Neil W.,KASPAREC, Jiri,KNIGHT, Steven David,LAFRANCE III, Louis V.,LUENGO, Juan I.,MILLER, William Henry,NEWLANDER, Kenneth Allen
申请号：
CL2015003200
公开号：
CL2015003200A1
申请日:
2015.10.30
申请国别(地区):
CL
年份:
2016
代理人:
摘要：
Compounds derived from N - ((2 - oxo - 1.2 - dihidropiridin - 3 - yl) methyl) - carboxamide,Inhibitors of Enhancer of zeste homolog 2 (Ezh2)； Pharmaceutical composition that comprises； a method for treating cancer； and its use for the treatment of a disorder mediated by Ezh2.<；p>；COMPUESTOS DERIVADOS DE N-((2-OXO-1,2-DIHIDROPIRIDIN-3-IL)METIL)-CARBOXAMIDA, INHIBIDORES DEL POTENCIADOR DEL HOMOLOGO ZESTE 2 (EZH2)； COMPOSICION FARMACEUTICA QUE LOS COMPRENDE Y SU USO PARA EL TRATAMIENTO DE UN TRASTORNO MEDIADO POR EZH2 TAL COMO CÁ；NCER.<；/p>；
